# Adjusted Fibrinogen Replacement Strategy

> **NCT03444324** · PHASE3 · COMPLETED · sponsor: **Biotest** · enrollment: 222 (actual)

## Conditions studied

- Bleeding Disorder
- Hypofibrinogenemia; Acquired

## Interventions

- **BIOLOGICAL:** BT524
- **BIOLOGICAL:** FFP/Cryo

## Key facts

- **NCT ID:** NCT03444324
- **Lead sponsor:** Biotest
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-03
- **Primary completion:** 2023-09-25
- **Final completion:** 2023-11-21
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03444324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03444324, "Adjusted Fibrinogen Replacement Strategy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03444324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*